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Introduction: The prevalence of obesity and Type 2 diabetes mellitus (T2DM) among children and adolescents is
rising. Thyroid function has been associated with insulin resistance. There is scarce information about how thyroid
function could be related with cardiovascular risk or glucose homeostasis in adolescent.
Aim: To analyze how thyroid function is associated with insulin resistance and another cardiovascular risk factors in
healthy adolescents with risk factors to develop diabetes.
Methods: A prospective cross-sectional analysis was carried out on euthyroid, adolescents. considered at high risk to
develop Type 2 diabetes. Fasting blood samples were obtained. Thyroid function test and another cardiometabolic
parameters were assessed. A 75 grams oral glucose tolerance test was performed to calculate insulin resistance.
Results: One hundred adolescents were evaluated. The mean age was 15.9 ± 0.8 years, There is a negative correlation
between Fasting insulin, post glucose load insulin and HOMA IR. There were no correlation with Matsuda index. We
could not found any correlation with TSH values.
Conclusions: We found a correlation between fasting insulin, HOMA IR and serum thyroid hormones, we did not find
any relation with serum TSH. In euthyroid adolescents with risk factors to develop diabetes.
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Obesity and overweight epidemic represent a big chal-
lenge all over the world. In Mexico, the National Health
and Nutrition Survey (ENSANUT) 2012 data estimated
a prevalence of obesity of 13.3% among adolescents (12–
19 years) [1]. The chronic evolution of obesity generates
devastating consequences that are associated with early
mortality [2] As a consequence, the prevalence of Type
2 diabetes mellitus (T2DM) among children and adoles-
cents is rising [3]. Since more young individuals develop
T2DM, their propensity to develop diabetes related com-
plications is higher [4]. These complications result from
a continuous exposure to high plasma glucose values,
and can occur even in those individuals with impaired* Correspondence: mezh_74@yahoo.com
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article, unless otherwise stated.fasting glucose (IFG) or impaired glucose tolerance [5].
Despite the relative low prevalence of T2DM at early
adolescence, having high fasting plasma glucose (FPG)
level, even within the normoglycemic range, is a pre-
dictor of T2DM in younger adulthood. So, it is import-
ant to find in those high risk adolescents, early
biomarkers that could be associated with metabolic dys-
functions [6].
Recently, increased interest has focused on the associ-
ation between thyroid dysfunction and obesity, diabetes,
metabolic syndrome and other cardiovascular risk fac-
tors [7]. It is well known that patients with primary
hypothyroidism have a threefold greater risk for early
atherosclerosis, as shown independently for other risk
factors such as atherogenic lipid profile, hypertension,
and impaired endothelial function [8]. Whether subclin-
ical hypothyroidism has an influence on the same risk
factors, the association with atherosclerosis still isCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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others do not [10]. Moreover there are authors that have
postulated that this relationship could be present even
in patients considered with normal thyroid function.
Most of these studies have been performed in adults and
much of them in geriatrics population [11]. Until now
there is scarce information about how thyroid function
could be related with cardiovascular risk or glucose
homeostasis in adolescents [12,13]. Some of them are fo-
cused in type 1 diabetes patients [14]. Others consider pa-
tients with subclinical hypothyroidism [15,16]. There is
only one study that consider euthyroid adolescents [17].
The goal of the present paper is to analyze how thy-
roid function is associated with insulin resistance and
another cardiovascular risk factors in healthy adolescents
with risk factors to develop diabetes.Methods
Patients
A general meeting with first year of high school students
and their parents were performed in the Lic. Adolfo
Lopez Mateos UAEMex high school. First of all, a didac-
tic explanatory talk about diabetes epidemiology and
complications was given to all the participants. All pa-
tients with at least one risk factor to develop T2DM
were invited to participate in the study.
We considered as T2DM risk factors; first degree fam-
ily history and /or overweight or obesity, defined as a
BMI ≥ 25 or 30 respectively.Intervention
A standardized questionnaire which included items re-
garding demographic information, personal and family
medical history was applied to all the adolescents. As-
sistance by their parents to complete the questionnaire
was allowed if needed. . A formal invitation were send to
all the adolescents consider at high risk to develop dia-
betes to perform a lipid profile, thyroid function test and
a 75 grams oral glucose tolerance test. A visit was pro-
grammed at the Medical Sciences Research Center
(CICMED).Anthropometric measures
Height and weight were performed in all subjects. An-
thropometric measurements were taken in a standard-
ized manner. The blood pressure was taken using a
mercury sphygmomanometer with the subjects seated
for 5min prior to measurement. A daily calibrated
digital scale and stadimeter were used to measure body
weight and height. The waist circumference was mea-
sured midway between the lower rib margin and the iliac
crest in the horizontal plane with the patient standing.Laboratory
Fasting blood samples (9–12h fast) were obtained. A 75
grams oral glucose tolerance test was performed, plasma
glucose and insulin were measured before and at minute
60 and 120 after the ingestion of 75 g of glucose.
The components of the metabolic syndrome were de-
fined in accordance with modified Cook adaptation for
adolescents of the National Cholesterol, Education Pro-
gram, Adult Treatment Panel III criteria (NCEP/ATPIII)
[18]; abdominal obesity (waist circumference ≥ percentile
90), hypertriglyceridemia (triglycerides ≥110 mg/dl.), low
HDL cholesterol (HDL cholesterol ≤40 mg/dl), elevated
arterial blood pressure (blood pressure ≥ percentile 90),
and abnormal fasting glucose (blood glucose ≥110 mg/dl).
The metabolic syndrome was diagnosed in the presence
of three or more of these factors. Insulin resistance was
measured using Matsuda Index using the validated by
the author 3 time points [19]. HOMA IR was calculated
using the following formula: (Glucose (mg/dl) × insulin
(μU/ml))/405 [20].
All blood samples were analyzed in the laboratory of
the CICMED “Universidad Autonoma del Estado de
México”, Toluca, Mexico. Analysis of the glucose and
lipid samples was carried on the same day as blood sam-
pling. Serum from each study subject was stored at −70°C
for later analysis.
Plasma glucose was measured with the oxidized glucose
method (Randox Laboratories Ltd, Antrim, UK), triglycer-
ides with a colorimetric method following enzymatic hy-
drolysis performed with the lipase technique, and HDL
cholesterol (HDL-C) by the clearance method. All bio-
medical assays were performed with a Selectra XL inst-
rument (Randox Laboratories Ltd, Antrim, UK). Thyroid
stimulating hormone (TSH), total tri-iodothyronine
(TT3), total thyroxine (TT4) free tri-iodothyronine (fT3),
free thyroxine (fT4) were analyzed on a high throughput
automated biochip immunoassay system, Evidence®, Ran-
dox Laboratories Ltd. Insulin was measured by Elisa
through Elycsys and Cobas Analyzers Roche Diagnostics®.
Ethics
The study was approved by the Institutional Review
Board of Medical Sciences Research Center (CICMED)
and informed written consent was obtained from each
patient before participation.
Statistical analyses
The descriptive analysis was performed using means and
standard deviations for continuous variables. Qualitative
variables were expressed as percentages. Kolmogorov-
Smirnov test was performed to analyses variable distri-
butions. Means comparison was performed using the
Student’s t-test for quantitative variables with a normal
distribution and with the Mann–Whitney U test for those
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proportions in qualitative variables. The correlation of
continuous variables was calculated using Spearman or
Pearson test as appropriate. Statistical tests were per-
formed using SPSS version 14 for Windows, Chicago, IL,
USA.Results
A total of 525 adolescents in their first grade of high
school answer the questionnaire. Oral glucose tolerance
test was performed in 100 adolescents. The mean age
was 15.9 ± 0.8 years, 64% of the patients were female,
the mean body mass index (BMI) was 23.6 ± 5.5 kg/m2,
and the mean waist circumference was 82.7 ± 10 cm.
The prevalence of overweight and obesity (BMI > 25kg/
m2) was 41%. The prevalence of metabolic syndrome
was 17%. The basal metabolic risk factors by sex are pre-
sented in Table 1.
A complete thyroid function test (TT4, TT3 FT3 FT4
and TSH) was measured in all subjects. There were no
patients with overt thyroid disease found. Only 8 pa-
tients have TSH values > 4mUI and only 2 of them more
than 5 m UI. All these patients had Thyroid hormones
in normal range.
FT4 was lower in patients with HDL ≤ 40 mg/dl com-
pared with those with HDL > 40 mg/dl 17.8 ± 0.3 vs 18.9
± 0.3 p < 0.048 There were no difference in thyroid hor-
mone or TSH concentration classifying by metabolic
syndrome or the rest of their components or categoriz-
ing by overweight or obesity (data not shown).
When we evaluate the correlation between the meta-
bolic variables TSH and FT4 we found that there is a
negative correlation between FT4 fasting insulin, post
glucose load insulin and HOMA IR. There were noTable 1 Basal characteristics
Male Female P
Glucose mg/dl 92 ± 1.2 90 ± 0.7 0.08
2 hour postload glucose mg/dl 98 ± 4.1 102 ± 2.2 0.45
Insulin mUI 14 ± 1.3 13.8 ± 7.2 0.87
HOMA IR 2.9 ± 0.3 2.7 ± 0.1 0.58
Matsuda Index 14 ± 0.8 10 ± 2.2 0.72
BMIkg/m2 25 ± 3.7 22 ± 5.5 0.03
Waist cm 86.60 ± 2.0 80 ± 1.1 0.01
Cholesterol mg/dl 156 ± 4.9 173 ± 4.5 0.21
Triglycerides mg/dl 128 ± 13 117 ± 7.7 0.42
HDL C mg/dl 39 ± 1.4 45 ± 1.2 0.01
LDL C mg/dl 101 ± 4.6 108 ± 3.9 0.22
Systolic Blood Pressure mm Hg 112 ± 2.6 106 ± 1.7 0.54
Diastolic Blood pressure mm Hg 66 ± 1.4 64 ± 0.9 0.23correlation between FT4 and Matsuda index. We could
not found any correlation with TSH values (Table 2).
When we compare the effect of thyroid function test
between having or not the type 2 diabetes risk factors
(overweight, obesity or positive family history) we did
not find any difference.
Discussion
In the present study, we analyzed the relationship be-
tween thyroid function, insulin resistance and other car-
diovascular risk factors. The study sample consisted in
healthy adolescents without diabetes or known thyroid
dysfunction with at least one risk factor to develop dia-
betes. Thyroid hormones serum concentrations seem to
be similar when we stratified for the different T2DM risk
factors. Moreover it exist correlation between thyroid
hormones and insulin during the OGTT and HOMA IR.
TSH values do not seem to correlate with insulin resist-
ance markers.
In the last 3 decades obesity in childhood has increas-
ing worldwide [21]. Associated with this phenomena
T2DM has turn in a public health problem [22]. In ado-
lescents the proportion between type 1 and T2DM has
been modified [23]. It is estimated that T2DM in chil-
dren all over the world contributing up to 45% of all
cases of Diabetes. In the last years genetic background
has taken an special relevance in the risk to develop
T2DM [24]. It is estimated than seventy five percent of
the cases have strong family history. This is of special
relevant in hispanic populations. The SEARCH for Dia-
betes in Youth population based study found the propor-
tion of T2DM among 10–19 years olds for Hispanics, is
33% [25]. In the present group we did not find new cases
of diabetes or impaired glucose tolerance moreover the
prevalence of metabolic syndrome is similar to that re-
ported by other authors in Mexican adolescents using
similar criteria [26].
Thyroid disease and diabetes mellitus are the two most
common endocrine disorders in everyday practice. The
possible association between both, and with other re-
lated diseases like dyslipidemia or cardiovascular disease
has been postulated for several authors [27]. It is well
recognized that overt thyroid dysfunction can produce
dyslipidemia and insulin resistance. In the case of sub-
clinical dysfunction is still controversial this possible as-
sociation. The positive or negative results had depended
on the studied populations [28]. Until the moment most
of the studies has been performed in adults or geriatrics
patients [29]. The correlation between thyroid hormones
and insulin resistance has been tested in diabetic pa-
tients but also in subjects with normal glucose tolerance
[30]. Even subtle decrease in the level of thyroid hor-
mones within the normal range has been shown to in-
versely correlate with insulin resistance [31]. It is well
Table 2 Linear correlations of thyroid function parameters and metabolic markers
T4 T3 FT FT3 TSH
Body Mass Index R −0.152 0.192 −0.202 0.052 −0.085
P value 0.137 0.059 0.047 0.614 0.407
Waist R 0.000 0.197 −0.163 −0.013 0.054
P value 0.998 0.053 0.110 0.900 0.602
Sistolic blood Pressure R 0.015 −0.017 −0.178 0.054 −0.172
P value 0.884 0.871 0.087 0.610 0.098
Diastolic Blood Pressure r 0.053 0.014 0.050 −0.025 −0.234
P value 0.614 0.892 0.633 0.811 0.024
Total cholesterol r −0.020 0.140 0.042 0.198 0.119
P value 0.845 0.166 0.681 0.050 0.239
Triglycerids r −0.242 0.153 −0.156 −0.006 0.084
P value 0.016 0.133 0.124 0.950 0.409
HDL Cholesterol r 0.108 −0.060 0.176 0.000 0.110
P value 0.288 0.555 0.082 0.999 0.278
LDL Cholesterol r 0.073 0.151 0.055 0.280 0.083
P value 0.474 0.137 0.588 0.005 0.416
Fasting Glucose r −0.005 0.210 −0.089 0.071 −0.064
P value 0.964 0.037 0.384 0.483 0.529
Glucose 60 min post load r 0.006 0.105 −0.020 0.113 0.016
P value 0.952 0.303 0.846 0.268 0.878
Glucose 120 min post load r −0.069 0.101 −0.073 0.141 −0.006
P value 0.500 0.320 0.473 0.167 0.956
Fasting Insulin r −0.223 −0.260 −0.212 0.043 0.000
P value 0.026 0.009 0.034 0.673 0.998
Insulin 60 minutes r −0.101 0.091 −0.257 −0.043 0.035
P value 0.321 0.369 0.010 0.669 0.727
Insulin 120 minutes r 0.032 −0.002 −0.246 −0.073 0.064
P value 0.755 0.985 0.016 0.477 0.537
HOMA IR r −0.186 0.293 −0.196 0.077 −0.021
P value 0.065 0.003 0.050 0.446 0.833
Matsuda Index r −0.030 −0.050 0.116 −0.034 −0.160
P value 0.774 0.632 0.261 0.747 0.120
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crease of insulin sensitivity and beta cell function [32]. It
exist very few information how thyroid function could be
related with insulin sensitivity in early stages of the life.
Non congenital thyroid dysfunction has a relatively low
prevalence in adolescents and children. A cohort study in
the pediatric population, shows that initial normal or
slightly elevated TSH levels are likely to remain normal or
spontaneously normalize without treatment [33]. Several
studies have confirmed the positive relationship between
weight status and TSH levels in childhood [34,35] 10–23%
of all obese children have moderately elevated TSH levels
(usually between4 and 10 mIU/l), which are associatedwith normal free T4 (fT4) [36]. In our study we did not
find correlation of the BMI with TSH or high prevalence
of elevated TSH, the big difference was that we did not
consider only obese patients. Sert et al. demonstrated that
elevated TSH in the a obese group with fatty liver were
positively correlate with most of the metabolic and cardio-
vascular risk parameters this was not shown in lean con-
trol subjects. [12].
Difference insulin resistance indexes between subclin-
ical and euthyroid subjects were described by Maratou
[37]. In our study we found correlation with thyroid hor-
mones and HOMA IR and basal Insulin, moreover there
were not with Matsuda Index. This difference could be
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resistance index that is related with liver insulin resist-
ance, on the contrary, Matsuda Index is an insulin sensi-
tivity index that calculate in an indirect way the insulin
sensitivity in muscle after a glucose load [38]. The thy-
roid hormones exert their physiological effects by bind-
ing to specific nuclear receptors [thyroid hormone
receptors (TR)] of which the TRβ isoform is liver specific
and has been considered a putative target for the treat-
ment of dyslipidemia and fatty liver [39]. The beneficial
effects of TRβ activation include lowering low-density
lipoprotein (LDL) cholesterol, reducing whole body adi-
posity and weigh. This could hypostatized that more of
the relation between insulin action and thyroid function
acts at liver, in a healthy adolescents with adequate
muscle metabolic function this seems to do not have big
impact. This has to be confirmed with future mechanis-
tic studies. The strength of this paper was the first in
evaluate the relationship of thyroid function and insulin
resistance with a dynamic test in euthyroid adolescents
with diabetes risk factors, the weakness is the cross sec-
tional design.
In summary we found a correlation between fasting in-
sulin, HOMA IR and serum thyroid hormones, we did
not find any relation with serum TSH. In euthyroid ado-
lescents with risk factors to develop diabetes. We con-
sidered that most research has to be done in children
and adolescents to find early markers than can predis-
pose to develop T2DM which will be come in the future
the most serious health problem all over the world.
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